Latest Global Markets News

First Graphene Limited strengthens its financial footing with a UK R&D tax rebate and expands its global footprint through new distribution agreements in India and Brazil.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Wellnex Life has negotiated a delayed and reduced-cost payment arrangement for its Pain Away acquisition, aligning with its upcoming London Stock Exchange dual listing plans. The move supports the company’s growth momentum following record revenues from Pain Away.

Qoria Limited reports robust December quarter results for FY2025, driven by strong ARR growth, expanding global reach, and strategic AI innovations that promise to accelerate future growth.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.

Montaka Global Long Only Equities Fund has announced a distribution of 11.30 cents per unit for the half-year ending 31 December 2024, continuing its commitment to delivering steady income alongside capital growth.

Premier Investments reveals a steady sales performance despite ongoing cost-of-living challenges, while preparing for a strategic merger with Myer.

Vection Technologies has secured a key distribution agreement to enter the Bulgarian market and partnered with DigiLens to integrate XR apps into advanced smart glasses, signaling a strategic push into Europe and global industrial sectors.

Peninsula Energy has appointed George Bauk as its new Managing Director and CEO, marking a strategic leadership transition aimed at capitalising on a resurging uranium market and expanding production at the Lance Project.